Les prix des medicaments sur un marche global politiques et enjeux.

Gorde:

Xehetasun bibliografikoak
Egile korporatiboa:	Organisation for Economic Co-operation and Development, ProQuest (Firm)
Formatua:	Baliabide elektronikoa eBook
Hizkuntza:	frantsesa
Argitaratua:	Paris : OCDE, 2008.
Gaiak:	Drugs > Prices. Pharmaceutical industry. Pharmaceutical industry > Government policy. Electronic books.
Sarrera elektronikoa:	Click to View
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak: Les prix des medicaments sur un marche global

Quick Look
Les prix des medicaments sur un marche global politiques et enjeux.
Quick Look
Pharmaceutical pricing policies in a global market
Quick Look
Pharmaceutical pricing policies in a global market
Quick Look
Generic drugs the pay-for-delay problem /
Quick Look
Generic drugs the pay-for-delay problem /
Quick Look
Pharmaceutical economics and policy
Quick Look
Pharmaceutical economics and policy
Quick Look
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Quick Look
The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
Quick Look
The perception of Kenyan doctors on the various differentiation strategies used by multinationals to build brand equity within the pharmaceutical industry /
Quick Look
The perception of Kenyan doctors on the various differentiation strategies used by multinationals to build brand equity within the pharmaceutical industry /
Quick Look
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Quick Look
The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
Quick Look
Profits before people? ethical standards and the marketing of prescription drugs /
Quick Look
Profits before people? ethical standards and the marketing of prescription drugs /
Quick Look
CAPA for the FDA-regulated industry /
Quick Look
CAPA for the FDA-regulated industry /
Quick Look
The $800 million pill the truth behind the cost of new drugs /
Quick Look
The $800 million pill the truth behind the cost of new drugs /
Quick Look
Pharmaceutical blending and mixing /
Quick Look
Pharmaceutical blending and mixing /
Quick Look
Marketing strategies adopted by generic and original drugs companies in an effort to attain strategic competitiveness: a study of Mombasa /
Quick Look
The agile approach to adaptive research optimizing efficiency in clinical development /
Quick Look
Therapeutic targets modulation, inhibition, and activation /